Benzinga · Sep 25, 2026
India Government Seeking Nationwide Crackdown On Nicotine Pouches Due To Health Risks
– Reuters cites India Ministry of Health and Family Welfare letter
NASDAQ · PMI
Healthcare · Medical - Devices
$4.61
Down-$0.11 (-2.39%)
Updated Sep 29, 2026, 4:49 PM
SID Score
3.8/10
Composite research score
Smart Money
58/100
Neutral
Price performance · PMI
1M range · 20 trading sessions · Daily adjusted prices
Prices through Sep 28, 2026
PMI closed at $4.61 after 20 trading sessions, down 45.51% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 28, 2026 | $4.49 | $4.7498 | $4.0301 | $4.61 | 52.04K |
| Sep 25, 2026 | $4.72 | $4.80 | $4.56 | $4.62 | 34.37K |
| Sep 24, 2026 | $4.50 | $4.87 | $4.28 | $4.87 | 56.98K |
| Sep 23, 2026 | $4.25 | $4.58 | $4.25 | $4.55 | 92.47K |
| Sep 22, 2026 | $3.89 | $4.33 | $3.83 | $4.33 | 216.27K |
| Sep 21, 2026 | $4.36 | $4.639 | $4.20 | $4.21 | 173.62K |
| Sep 18, 2026 | $5.62 | $5.705 | $4.91 | $5.08 | 213.49K |
| Sep 17, 2026 | $6.40 | $7.10 | $5.50 | $5.60 | 218.47K |
| Sep 16, 2026 | $6.18 | $6.81 | $6.12 | $6.48 | 146.35K |
| Sep 15, 2026 | $6.07 | $6.8699 | $6.0002 | $6.39 | 285.33K |
| Sep 14, 2026 | $5.51 | $6.40 | $5.51 | $6.26 | 588.93K |
| Sep 11, 2026 | $4.56 | $5.33 | $4.55 | $5.33 | 523.24K |
| Sep 10, 2026 | $4.30 | $5.00 | $4.18 | $4.41 | 321.91K |
| Sep 9, 2026 | $4.25 | $4.65 | $4.0459 | $4.41 | 250.24K |
| Sep 8, 2026 | $4.70 | $4.77 | $4.24 | $4.31 | 197.48K |
| Sep 4, 2026 | $4.46 | $5.3521 | $4.3447 | $4.56 | 513.18K |
| Sep 3, 2026 | $4.54 | $4.60 | $4.1005 | $4.49 | 306.95K |
| Sep 2, 2026 | $3.87 | $4.78 | $3.5015 | $4.58 | 828.67K |
| Sep 1, 2026 | $8.24 | $8.97 | $3.80 | $3.86 | 1.6M |
| Aug 31, 2026 | $8.04 | $11.87 | $7.92 | $8.46 | 2.25M |
The latest Smart Investors Daily articles mentioning PMI.
PMI research
Company profile and research snapshot.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 3, 2026 | HC Wainwright & Co. | Neutral | — |
| May 18, 2026 | HC Wainwright & Co. | Neutral | — |
No generated briefing is available yet.
Benzinga · Sep 25, 2026
– Reuters cites India Ministry of Health and Family Welfare letter
ChartMill · Sep 14, 2026
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Benzinga · Sep 14, 2026
Gainers Basel Medical Group (NASDAQ:BMGL) shares moved upwards by 59.8% to $7.32 during Monday's regular session. Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 45.18% to $2.41. The company's
Benzinga · Sep 10, 2026
Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 8.9% to $0.32 during Thursday's after-market session. The company's market cap stands at $11.5 million. Picard Medical (AMEX:PMI) stock moved upwards
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning PMI.